The global microtome market size is expected to reach USD 233.0 million by 2030, registering a CAGR of 6.4% from 2023 to 2030, according to a new report by Grand View Research, Inc. Growing awareness about early diagnosis of chronic diseases and increasing demand for technologically advanced diagnostic equipment are some of the key factors anticipated to drive the market.
According to the estimates of Laboratory Economics, in 2012, over USD 20 billion was spent on laboratory mergers between 1996 and 2011. In 2011, approximately USD 3.5 billion was spent on laboratory mergers. Increasing worldwide geriatric population, growing healthcare expenditure, and rising patient awareness regarding early disease diagnosis are some of the key factors expected to propel the tissue diagnostics market. This, in turn, is likely to boost demand for tissue slicing equipment. However, reimbursement cuts and hospital consolidation are some of the factors expected to hamper growth.
Although the U.S. ranks first in terms of per capita healthcare spending, spending on clinical laboratories is significantly lower as compared to other healthcare aspects. Moreover, overall growth in the clinical laboratory market is majorly dependent on demographic factors, technological, medical, & scientific advancements, and disease burden specific to that region. Developed economies, such as the U.S., Germany, Japan, Canada, and France, have huge R&D budgets, higher technological advancements, and more awareness regarding various health aspects as compared to developing economies. This is likely to account for majority of the share in these regions.
Growing number of histopathology laboratories, high growth potential of anatomical pathology labs in emerging economies, and rising awareness regarding digital pathological systems are some key attributes that can provide new opportunities to players. Adoption rate of histology equipment is expected to gain substantial momentum owing to growing usage of technologically advanced biomarkers in diagnosing various diseases such as cancer and other infectious diseases.
Request a free sample copy or view report summary: Microtome Market Report
The global microtome market size was estimated at USD 142.4 million in 2022 and is expected to grow at a CAGR of 6.4% from 2023 to 2030
The microtome devices segment emerged as the largest product segment in 2022
Microtome accessories such as blades, blade holders, and clamps is anticipated to witness fastest growth over the next eight years
The Asia Pacific region is anticipated to witness lucrative growth over the next decade. It is expected to grow at a CAGR of 7.6% over the forecast period
Some of the key players are Diapath S.P.A.; Leica Biosystems Nussloch GmbH; Sakura Finetek Europe B.V.; MEDITE GmbH; SLEE medical GmbH; Boeckeler Instruments; Nanolytik; S.M. Scientific Instruments Pvt. Ltd.; AGD Biomedicals; Alltion; Amos Scientific Pvt. Ltd.; Thermo Fisher Scientific
Grand View Research has segmented the microtome market based on product, technology, and region:
Microtome Product Outlook (Revenue, USD Million, 2018 - 2030)
Microtome Devices
Rotary Microtome
Vibrating Microtome
Other Microtome
Accessories
Microtome Technology Outlook (Revenue, USD Million, 2018 - 2030)
Fully Automated
Semi-Automated
Manual
Microtome Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Sweden
Norway
Denmark
Asia Pacific
China
Japan
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East and Africa
Saudi Arabia
South Africa
UAE
Kuwait
List Of Key Players Microtome Market
Diapath S.P.A.
Leica Biosystems Nussloch GmbH
Sakura Finetek Europe B.V.
MEDITE GmbH
SLEE medical GmbH
Boeckeler Instruments
Nanolytik
S.M. Scientific Instruments Pvt. Ltd.
AGD Biomedicals
Alltion
Amos Scientific Pvt. Ltd.
Thermo Fisher Scientific
"The quality of research they have done for us has been excellent..."